← Back to Clinical Trials
Recruiting Phase 2 NCT06141447
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Trial Parameters
Condition Hemorrhage
Sponsor University of Colorado, Denver
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 150
Sex FEMALE
Min Age 18 Years
Max Age 55 Years
Start Date 2024-05-02
Completion 2026-11-02
Interventions
Oxytocin + normal salineNormal saline
Brief Summary
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
Eligibility Criteria
Inclusion Criteria: * clinic-based D\&E at 18 weeks gestational age and above * speaks English or Spanish Exclusion Criteria: * refuses IV * history of coagulopathy * anticoagulant use in the preceding five days * chorioamnionitis or sepsis * suspected placenta accreta spectrum * intrauterine fetal demise * multiple gestation * use of misoprostol for cervical preparation